LIXTE BIOTECHNOLOGY HOLDINGS, INC. Quarterly Return On Assets in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Lixte Biotechnology Holdings, Inc. quarterly/annual Return On Assets history and growth rate from Q1 2012 to Q3 2024.
  • Lixte Biotechnology Holdings, Inc. Return On Assets for the quarter ending September 30, 2024 was -131 %, a 4.56% decline year-over-year.
  • Lixte Biotechnology Holdings, Inc. annual Return On Assets for 2023 was -120 %, a 16.5% decline from 2022.
  • Lixte Biotechnology Holdings, Inc. annual Return On Assets for 2022 was -103 %, a 1.62% decline from 2021.
  • Lixte Biotechnology Holdings, Inc. annual Return On Assets for 2021 was -101 %, a 16.5% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -131 -5.69 -4.56% Jul 1, 2024 Sep 30, 2024
Q2 2024 -102 +22 +17.7% Apr 1, 2024 Jun 30, 2024
Q1 2024 -116 -18.2 -18.7% Jan 1, 2024 Mar 31, 2024
Q4 2023 -120 -16.9 -16.5% Oct 1, 2023 Dec 31, 2023
Q3 2023 -125 -13.2 -11.9% Jul 1, 2023 Sep 30, 2023
Q2 2023 -124 -14.3 -13% Apr 1, 2023 Jun 30, 2023
Q1 2023 -97.4 +19.5 +16.7% Jan 1, 2023 Mar 31, 2023
Q4 2022 -103 -1.64 -1.62% Oct 1, 2022 Dec 31, 2022
Q3 2022 -112 -27.6 -32.8% Jul 1, 2022 Sep 30, 2022
Q2 2022 -110 +0.08 +0.07% Apr 1, 2022 Jun 30, 2022
Q1 2022 -117 -4.28 -3.8% Jan 1, 2022 Mar 31, 2022
Q4 2021 -101 +20.1 +16.5% Oct 1, 2021 Dec 31, 2021
Q3 2021 -84 +46.7 +35.7% Jul 1, 2021 Sep 30, 2021
Q2 2021 -110 -22.8 -26.2% Apr 1, 2021 Jun 30, 2021
Q1 2021 -113 -30.3 -36.7% Jan 1, 2021 Mar 31, 2021
Q4 2020 -121 -48.1 -65.5% Oct 1, 2020 Dec 31, 2020
Q3 2020 -131 -64.8 -98.4% Jul 1, 2020 Sep 30, 2020
Q2 2020 -87.1 -8.72 -11.1% Apr 1, 2020 Jun 30, 2020
Q1 2020 -82.3 +11.3 +12.1% Jan 1, 2020 Mar 31, 2020
Q4 2019 -73.3 +63.9 +46.6% Oct 1, 2019 Dec 31, 2019
Q3 2019 -65.9 +207 +75.9% Jul 1, 2019 Sep 30, 2019
Q2 2019 -78.4 +69.3 +46.9% Apr 1, 2019 Jun 30, 2019
Q1 2019 -93.7 +11.9 +11.2% Jan 1, 2019 Mar 31, 2019
Q4 2018 -137 -16.7 -13.9% Oct 1, 2018 Dec 31, 2018
Q3 2018 -273 -124 -82.8% Jul 1, 2018 Sep 30, 2018
Q2 2018 -148 +43.1 +22.6% Apr 1, 2018 Jun 30, 2018
Q1 2018 -106 +150 +58.6% Jan 1, 2018 Mar 31, 2018
Q4 2017 -120 +94.6 +44% Oct 1, 2017 Dec 31, 2017
Q3 2017 -149 +66.7 +30.9% Jul 1, 2017 Sep 30, 2017
Q2 2017 -191 +32.9 +14.7% Apr 1, 2017 Jun 30, 2017
Q1 2017 -255 -43.9 -20.8% Jan 1, 2017 Mar 31, 2017
Q4 2016 -215 +21 +8.91% Oct 1, 2016 Dec 31, 2016
Q3 2016 -216 +21.4 +9.03% Jul 1, 2016 Sep 30, 2016
Q2 2016 -224 -8.26 -3.83% Apr 1, 2016 Jun 30, 2016
Q1 2016 -211 +36.1 +14.6% Jan 1, 2016 Mar 31, 2016
Q4 2015 -236 +130 +35.4% Oct 1, 2015 Dec 31, 2015
Q3 2015 -237 +95.1 +28.6% Jul 1, 2015 Sep 30, 2015
Q2 2015 -215 +105 +32.8% Apr 1, 2015 Jun 30, 2015
Q1 2015 -247 +37.6 +13.2% Jan 1, 2015 Mar 31, 2015
Q4 2014 -366 -230 -170% Oct 1, 2014 Dec 31, 2014
Q3 2014 -333 -234 -238% Jul 1, 2014 Sep 30, 2014
Q2 2014 -321 -134 -71.9% Apr 1, 2014 Jun 30, 2014
Q1 2014 -285 -107 -59.8% Jan 1, 2014 Mar 31, 2014
Q4 2013 -136 +96.5 +41.6% Oct 1, 2013 Dec 31, 2013
Q3 2013 -98.4 +230 +70% Jul 1, 2013 Sep 30, 2013
Q2 2013 -187 +90.9 +32.8% Apr 1, 2013 Jun 30, 2013
Q1 2013 -178 +124 +41.1% Jan 1, 2013 Mar 31, 2013
Q4 2012 -232 Oct 1, 2012 Dec 31, 2012
Q3 2012 -328 Jul 1, 2012 Sep 30, 2012
Q2 2012 -277 Apr 1, 2012 Jun 30, 2012
Q1 2012 -303 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.